Generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) agreed to make broad changes at its plants in the United States and India as part of a long-running U.S. government probe, the Justice Department s

New Delhi: Ranbaxy, controlled by Japan's Daiichi Sankyo, only reported full-year results and declined to comment on what caused the loss. A Reuters calculation showed the fourth-quarter net loss at 9

India's drug manufacturing major Ranbaxy Laboratories Limited Thursday reported a 168 percent jump in the net profit for the third quarter of 2010 ending Sep 30 at Rs.308 crore as against Rs.115 crore